They have also previously reported that the inhibition of TLR4 by a TLR4 antagonist in a collagen-induced RA mouse model (CIA) repressed the clinical manifestations and the severity of arthritis [170]. The gene discussed is TLR4; the disease is rheumatoid arthritis.